liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Helsinki Univ Hosp, Finland; Univ Helsinki, Finland.
Helsinki Univ Hosp, Finland; Univ Helsinki, Finland.
Univ Klinikum RWTH Aachen, Germany.
Univ Bergen, Norway; Univ Bergen, Norway.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Oncoimmunology, ISSN 2162-4011, E-ISSN 2162-402X, Vol. 8, nr 9, artikkel-id e1638210Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Changes in the immune system induced by tyrosine kinase inhibitors (TKI) have been shown to positively correlate with therapy responses in chronic myeloid leukemia (CML). However, only a few longitudinal studies exist and no randomized comparisons between two TKIs have been reported. Therefore, we prospectively analyzed the immune system of newly diagnosed CML patients treated with imatinib (n = 20) or bosutinib (n = 13), that participated in the randomized BFORE trial (NCT02130557). Comprehensive immunophenotyping, plasma protein profiling, and functional assays to determine activation levels of T and NK cells were performed at diagnosis, 3, and 12 months after therapy start. All results were correlated with clinical parameters such as Sokal risk and BCR-ABL load measured according to IS%. At diagnosis, low Sokal risk CML patients had a higher frequency of cytotoxic cells (CD8 + T and NK cells), increased cytotoxic potential of NK cells and lower frequency of naive and central memory CD4 + T cells. Further, soluble plasma protein profile divided patients into two distinct clusters with different disease burden at diagnosis. During treatment, BCR-ABL IS% correlated with immunological parameters such as plasma proteins, together with different memory subsets of CD4+ and CD8 + T cells. Interestingly, the proportion and cytotoxic potential of NK cells together with several soluble proteins increased during imatinib treatment. In contrast, no major immunological changes were observed during bosutinib treatment. In conclusion, imatinib and bosutinib were shown to have differential effects on the immune system in this randomized clinical trial. Increased number and function of NK cells were especially observed during imatinib therapy.

sted, utgiver, år, opplag, sider
Taylor & Francis, 2019. Vol. 8, nr 9, artikkel-id e1638210
Emneord [en]
CML; imatinib; bosutinib; Sokal; BCR-ABL
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-159139DOI: 10.1080/2162402X.2019.1638210ISI: 000476301700001PubMedID: 31428530Scopus ID: 2-s2.0-85069049177OAI: oai:DiVA.org:liu-159139DiVA, id: diva2:1339525
Merknad

Funding Agencies|Pfizer investigator grant; Finnish Cancer Organizations; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Helsinki Institute of Life Sciences (HiLife); Finnish Cancer Institute

Tilgjengelig fra: 2019-07-30 Laget: 2019-07-30 Sist oppdatert: 2019-11-13bibliografisk kontrollert

Open Access i DiVA

fulltext(6139 kB)8 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 6139 kBChecksum SHA-512
d388bb166e015aadef12017b9a4eba1e29b307686dd60e938123c88ef43bc8d32a0e588650b38360cfbd796794ba4d9b7ce6330615b29467db74e0bffa74d3fa
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Lotfi, Kourosh

Søk i DiVA

Av forfatter/redaktør
Lotfi, Kourosh
Av organisasjonen
I samme tidsskrift
Oncoimmunology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 8 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 27 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf